Signaling of type II oncostatin M receptor.

@article{Auguste1997SignalingOT,
  title={Signaling of type II oncostatin M receptor.},
  author={Patrick Auguste and Catherine Guillet and M Fourcin and Christophe Olivier and Joelle V{\'e}ziers and A Pouplard-Barthelaix and Hugues Gascan},
  journal={The Journal of biological chemistry},
  year={1997},
  volume={272 25},
  pages={15760-4}
}
Oncostatin M (OSM) mediates its bioactivities through two different heterodimer receptors. They both involve the gp130-transducing receptor, which dimerizes with either leukemia inhibitory receptor beta or with OSM receptor beta (OSMRbeta) to generate, respectively, type I and type II OSM receptors. Co-precipitation of gp130-associated proteins, flow cytometry, polymerase chain reaction, and tyrosine phosphorylation analyses allowed the characterization of both types of OSM receptors expressed… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 32 extracted citations

Interferon-γ is a master checkpoint regulator of cytokine-induced differentiation.

Proceedings of the National Academy of Sciences of the United States of America • 2017

Similar Papers

Loading similar papers…